|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross margin | |||||
| Operating costs and expenses: | |||||
| General and administrative | |||||
| Sales and marketing | |||||
| Product development | |||||
| Depreciation and amortization | |||||
| Impairment loss on intangible assets | |||||
| Impairment charges | |||||
| Total operating costs and expenses | |||||
| Operating loss | |||||
| Other income (expense) | |||||
| Interest expense, net | |||||
| Other expense (See Notes 6 and 7) | |||||
| Interest expense, net | |||||
| Other income (expense) (See Notes 6 and 7) | |||||
| Loss from continuing operations before income taxes | |||||
| Income tax benefit | |||||
| Net loss from continuing operations | |||||
| Net income from discontinued operations, net of taxes | |||||
| Net income (loss) | |||||
| Loss from continuing operations per share – basic | |||||
| Loss from continuing operations per share – diluted | |||||
| Income from discontinued operations per share – basic | |||||
| Income from discontinued operations per share – diluted | |||||
| Income (loss) per share – basic | |||||
| Income (loss) per share – diluted | |||||
| Weighted average number of common shares outstanding – basic | |||||
| Weighted average number of common shares outstanding – diluted | |||||
Loading...